Looking for help?

Find answers to your questions

Terpenes - Beta-caryophyllene

What is Beta-caryophyllene?

Beta-caryophyllene is a terpene commonly found in cannabis and other plants, such as black pepper, cloves, and cinnamon. It has a spicy, woody aroma and is known for its therapeutic properties. Beta-caryophyllene is also known as BCP and is one of the few terpenes that interacts directly with the body's endocannabinoid system.

History

Beta-caryophyllene was first identified in 1964 by researchers investigating the chemical composition of clove oil. It wasn't until much later that its interaction with the endocannabinoid system was discovered, and its potential therapeutic benefits began to be explored.

Chemistry

Beta-caryophyllene is a sesquiterpene, which means it contains three isoprene units. Its molecular formula is C15H24, and its boiling point is around 320°F (160°C). It is lipophilic, which means it is soluble in fats and oils but not in water.

Pharmacology

Beta-caryophyllene is unique among terpenes in that it is a selective agonist of the CB2 receptor, one of the two receptors in the endocannabinoid system. This means that it can have a direct effect on the immune system and can help reduce inflammation, pain, and anxiety. It is also thought to have analgesic, anti-inflammatory, and anti-anxiety properties.

Positive Effects

Research has shown that beta-caryophyllene has several potential therapeutic benefits. In addition to its anti-inflammatory, analgesic, and anti-anxiety properties, it may also have antioxidant and neuroprotective effects. Beta-caryophyllene has been studied for its potential in treating conditions such as arthritis, neuropathic pain, and anxiety.

Negative Effects

While beta-caryophyllene is generally considered safe, there are some potential risks and interactions to be aware of. Like many terpenes, it can be irritating to the skin and mucous membranes if used in high concentrations. It may also interact with certain medications, so it's important to talk to a healthcare provider before using it if you are taking any prescription drugs.

Combinations

Beta-caryophyllene is often found in combination with other terpenes and cannabinoids in cannabis strains. When combined with other compounds, it can contribute to the entourage effect, which refers to the idea that the various compounds in cannabis work together synergistically to enhance their therapeutic benefits. Some common terpenes found in cannabis strains with beta-caryophyllene include limonene, myrcene, and pinene.

Warnings

While beta-caryophyllene is generally considered safe, it is important to use caution when consuming it. It can interact with certain medications, and it may cause skin irritation if used in high concentrations. It is also important to use caution when consuming cannabis, as it can have potentially harmful effects on the developing brain and may interact with other medications.

Conclusion

Beta-caryophyllene is a terpene with unique pharmacological properties that make it useful in the treatment of various conditions. It is a selective agonist of the CB2 receptor and has anti-inflammatory, analgesic, and anti-anxiety properties. While it is generally considered safe, it can have some potential risks and interactions, and caution should be used when consuming it.

References

1. Gertsch, J., Leonti, M., Raduner, S., Racz, I., Chen, J. Z., Xie, X. Q., ... & Zimmer, A. (2008). Beta-caryophyllene is a dietary cannabinoid. Proceedings of the National Academy of Sciences, 105(26), 9099-9104.

2. Russo, E. B. (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology, 163(7), 1344-1364.

3. Gertsch, J. (2018). Botanical and biological sources of the endocannabinoid system. Handbook of Cannabis and Related Pathologies, 27-45.

4. Chagas, M. H. N., Zuardi, A. W., Tumas, V., Pena-Pereira, M. A., Sobreira, E. T., Bergamaschi, M. M., ... & Crippa, J. A. S. (2014). Effects of cannabidiol in the treatment of patients with Parkinson's disease: an exploratory double-blind trial. Journal of Psychopharmacology, 28(11), 1088-1098.

5. Gertsch, J., Pertwee, R. G., & Di Marzo, V. (2010). Phytocannabinoids beyond the Cannabis plant–do they exist?. British Journal of Pharmacology, 160(3), 523-529.

6. Kaur, R., Ambwani, S. R., & Singh, S. (2016). Endocannabinoid system: a multi-facet therapeutic target. Current clinical pharmacology, 11(2), 110-117.

Updated on 25 Apr 2023